Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASCADE: Clopidogrel for Saphenous Vein Graft Disease
NCT00228423Phase 2Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- May 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clopidogrel in atherosclerosis, sponsored by University of Ottawa Heart Institute. Started May 2006; status: completed.
02
Drugs
clopidogrel
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00228423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228423.